首页> 美国卫生研究院文献>BMC Neurology >Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial

【2h】

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial

机译：干扰素β-1a皮下每周三次治疗的复发性多发性硬化症的免疫学和短期脑容量变化：一项开放标签的两臂试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundBrain volume atrophy is observed in relapsing–remitting multiple sclerosis (RRMS).

机译：背景在复发缓解型多发性硬化症（RRMS）中观察到脑体积萎缩。

著录项

期刊名称 BMC Neurology
作者
Michael G. Dwyer; Robert Zivadinov; Yazhong Tao; Xin Zhang; Cheryl Kennedy; Niels Bergsland; Deepa P. Ramasamy; Jackie Durfee; David Hojnacki; Bianca Weinstock-Guttman; Brooke Hayward; Fernando Dangond; Silva Markovic-Plese;
展开▼
作者单位

展开▼
年(卷),期 2015(15),-1
年度 2015
页码 232
总页数 11
原文格式 PDF
正文语种
中图分类神经病学;
关键词
Multiple sclerosis Pseudoatrophy Interferon Brain volumetry Magnetic resonance imaging;

机译：多发性硬化症;假性萎缩;干扰素;脑容量测定;磁共振成像;
入库时间 2022-08-17 14:15:08

相似文献

外文文献
中文文献
专利

1. Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial [J] . Michael G Dwyer, Robert Zivadinov, Yazhong Tao, BMC Neurology . 2015,第1期

机译：每周三次皮下注射干扰素β-1a的复发性多发性硬化症的免疫学和短期脑容量变化：一项开放标签的两臂试验
2. Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb study [J] . William Camu, Karim Hadjout, Sabine Latour, Patient Preference and Adherence . 2010,第2期

机译：在复发性多发性硬化症中从皮下干扰素β-1a的原始制剂转换为新制剂后的患者满意度：一项随机，两臂，开放标签的IIIb期研究
3. Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1 [J] . Anthony Traboulsee, David K. B. Li, Mark Cascione, BMC Neurology . 2018,第1期

机译：每周三次皮下注射干扰素β-1a对临床和放射学检查的影响，并且在复发的多发性硬化症患者中没有疾病活动状态的证据，在第1年
4. Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized two-arm open-label Phase IIIb study [O] . William Camu, Karim Hadjout, Sabine Latour, 2010

机译：在复发性多发性硬化中从皮下注射干扰素β-1a的原始制剂转变为新制剂后的患者满意度：一项随机两臂开放标签的IIIb期研究
5. Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial [O] . Michael G. Dwyer, Robert Zivadinov, Yazhong Tao, 2015

机译：干扰素β-1a皮下每周三次治疗的复发性多发性硬化症的免疫学和短期脑容量变化：一项开放标签的两臂试验

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial

摘要

著录项

相似文献

相关主题

期刊订阅